Edwards Lifesciences Corporation Common Stock vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.82 (market cap $48.56B), while Direxion Daily FTSE China Bull 3x Shares trades at $25.2 (market cap $560.32M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 86.7× Direxion Daily FTSE China Bull 3x Shares's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| EW | YINN | |
|---|---|---|
Market Cap | $48.56B | $560.32M |
Volume | 6,520,488 | 1,009,521 |
Sector | Health | Leveraged / Inverse |
52-Week High | $95.18 | $52.69 |
52-Week Low | $72.65 | $21.45 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 25 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN is trading at $25.09, up 6.49% in the past 24 hours, though technical indicators signal a bearish trend with 17 sell signals versus 2 buy signals. The stock faces resistance at $24 with support at $23. Recent news highlights China's economic policies and export controls, which may impact the underlying index exposure. Financial ratios remain unavailable for analysis.
The outlook is cautious due to bearish technicals and China-related macroeconomic risks. Opportunities exist if support holds and sentiment improves, but investors face volatility from regulatory developments and weak momentum. Risk management is essential given the conflicting signals between price action and technical indicators.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →